FLT3 Inhibitors
- 1 March 2004
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (5) , 707-721
- https://doi.org/10.1016/j.ejca.2003.08.030
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Potential Use of Imatinib in Ewing's Sarcoma: Evidence for In Vitro and In Vivo ActivityJNCI Journal of the National Cancer Institute, 2002
- A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemiaBlood, 2002
- Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitorLeukemia, 2002
- Human AML cells in NOD/SCID mice: engraftment potential and gene expressionLeukemia, 2002
- Clinical relevance of internal tandem duplication of theFLT3 gene in childhood acute myeloid leukemiaCancer, 2002
- Flt3 Ligand Induces Tyrosine Phosphorylation of Gab1 and Gab2 and Their Association with Shp-2, Grb2, and PI3 KinaseBiochemical and Biophysical Research Communications, 2000
- Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemiaLeukemia, 1999
- Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-mycOncogene, 1997
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cellsCell, 1993